162 related articles for article (PubMed ID: 18328152)
1. Treatment of rheumatoid arthritis patients with anti-TNF-alpha monoclonal antibody is accompanied by down-regulation of the activating Fcgamma receptor I on monocytes.
Wijngaarden S; van de Winkel JG; Bijlsma JW; Lafeber FP; van Roon JA
Clin Exp Rheumatol; 2008; 26(1):89-95. PubMed ID: 18328152
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment.
Wijngaarden S; van Roon JA; van de Winkel JG; Bijlsma JW; Lafeber FP
Rheumatology (Oxford); 2005 Jun; 44(6):729-34. PubMed ID: 15757966
[TBL] [Abstract][Full Text] [Related]
3. A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis.
Wijngaarden S; van de Winkel JG; Jacobs KM; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2004 Dec; 50(12):3878-87. PubMed ID: 15593228
[TBL] [Abstract][Full Text] [Related]
4. Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis.
Belostocki K; Pricop L; Redecha PB; Aydin A; Leff L; Harrison MJ; Salmon JE
Arthritis Rheum; 2008 Feb; 58(2):384-8. PubMed ID: 18240208
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated Fc receptor function in active rheumatoid arthritis.
Magnusson SE; Wennerberg E; Matt P; Lindqvist U; Kleinau S
Immunol Lett; 2014 Nov; 162(1 Pt A):200-6. PubMed ID: 25194756
[TBL] [Abstract][Full Text] [Related]
6. Fcgamma receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs.
Wijngaarden S; van Roon JA; Bijlsma JW; van de Winkel JG; Lafeber FP
Rheumatology (Oxford); 2003 May; 42(5):681-8. PubMed ID: 12709546
[TBL] [Abstract][Full Text] [Related]
7. Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis.
Abrahams VM; Cambridge G; Lydyard PM; Edwards JC
Arthritis Rheum; 2000 Mar; 43(3):608-16. PubMed ID: 10728755
[TBL] [Abstract][Full Text] [Related]
8. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
9. High synovial expression of the inhibitory FcgammaRIIb in rheumatoid arthritis.
Magnusson SE; Engström M; Jacob U; Ulfgren AK; Kleinau S
Arthritis Res Ther; 2007; 9(3):R51. PubMed ID: 17521421
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Fcgamma receptor I, alphaMbeta2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets.
Bunescu A; Seideman P; Lenkei R; Levin K; Egberg N
J Rheumatol; 2004 Dec; 31(12):2347-55. PubMed ID: 15570633
[TBL] [Abstract][Full Text] [Related]
12. Fcγ receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins.
Laurent L; Clavel C; Lemaire O; Anquetil F; Cornillet M; Zabraniecki L; Nogueira L; Fournié B; Serre G; Sebbag M
Ann Rheum Dis; 2011 Jun; 70(6):1052-9. PubMed ID: 21406456
[TBL] [Abstract][Full Text] [Related]
13. Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling Pathways.
Prins MM; Verstockt B; Ferrante M; Vermeire S; Wildenberg ME; Koelink PJ
Front Immunol; 2021; 12():627535. PubMed ID: 33790898
[TBL] [Abstract][Full Text] [Related]
14. Different types of FCgamma-receptors are involved in anti-Lewis Y antibody induced effector functions in vitro.
Dettke M; Loibner H
Br J Cancer; 2000 Jan; 82(2):441-5. PubMed ID: 10646902
[TBL] [Abstract][Full Text] [Related]
15. FcgammaRIIa is a target for modulation by TNFalpha in human neutrophils.
Belostocki K; Park MS; Redecha PB; Masuda E; Salmon JE; Pricop L
Clin Immunol; 2005 Oct; 117(1):78-86. PubMed ID: 16084773
[TBL] [Abstract][Full Text] [Related]
16. High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcgamma receptors on monocytes in patients with primary immune thrombocytopenia.
Liu XG; Ma SH; Sun JZ; Ren J; Shi Y; Sun L; Dong XY; Qin P; Guo CS; Hou M; Peng J
Blood; 2011 Feb; 117(6):2061-9. PubMed ID: 21131591
[TBL] [Abstract][Full Text] [Related]
17. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes.
Kirino Y; Takeno M; Murakami S; Kobayashi M; Kobayashi H; Miura K; Ideguchi H; Ohno S; Ueda A; Ishigatsubo Y
Arthritis Rheum; 2007 Feb; 56(2):464-75. PubMed ID: 17265482
[TBL] [Abstract][Full Text] [Related]
19. Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen.
Clavel C; Nogueira L; Laurent L; Iobagiu C; Vincent C; Sebbag M; Serre G
Arthritis Rheum; 2008 Mar; 58(3):678-88. PubMed ID: 18311806
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
